Clinical Trials Browser

Carcinoma, Hepatocellular × Irinotecan × 90 days × Clear all

NCT05669339 2026-02-18

AD HOC Trial: Artificial Intelligence-Based Drug Dosing In Hepatocellular Carcinoma

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular